Primary Pulmonary Carcinoid Tumor A Long-term Single Institution Experience Article

Herde, RF, Kokeny, KE, Reddy, CB et al. (2018). Primary Pulmonary Carcinoid Tumor A Long-term Single Institution Experience . AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 41(1), 24-29. 10.1097/COC.0000000000000221

cited authors

  • Herde, RF; Kokeny, KE; Reddy, CB; Akerley, WL; Hu, N; Boltax, JP; Hitchcock, YJ



  • Objectives: Primary carcinoid tumors of the lung are rare tumors which comprise approximately 0.5% to 5% of all lung malignancies in adults and roughly 20% to 30% of all carcinoid tumors. The purpose of this retrospective, descriptive study was to describe the incidence, characteristics, and outcomes of patients treated for primary pulmonary carcinoid tumor at a single institution. Materials and Methods: All patients with a diagnosis of primary pulmonary carcinoid tumor treated from 1989 to 2009 were reviewed. Data collected included demographics, pathology, tobacco use, clinical presentation, tumor location, tumor spread, treatment, and survival. Results: There were 59 cases of pulmonary carcinoid tumors: 47 typical (80%) and 12 atypical (20%). All but 4 patients underwent surgery, including 54 (92%) lung-sparing resections and 1 pneumonectomy. Five of 55 patients received concurrent adjuvant chemoradiation therapy; 4 patients with atypical and 1 with typical histology. Three additional patients with atypical carcinoid were treated only with adjuvant radiotherapy, palliative radiotherapy, or palliative chemotherapy, respectively. The Kaplan-Meier 5- and 10-year overall survivals were both 80% within the entire population. In the 88% of patients who achieved complete remission, disease-free survival was 98%. A review of a large series from the literature is also presented. Conclusions: Surgical resection was primary and adequate therapy for most typical carcinoid tumors with high overall survival and diseasefree survival. Adjuvant chemotherapy or radiotherapy might be considered for patients with atypical carcinoid tumors who present with adverse pathologic findings.

publication date

  • January 1, 2018

Digital Object Identifier (DOI)

start page

  • 24

end page

  • 29


  • 41


  • 1